
Spanish sector attracting more and more investment
According to Spain's biotech association, the investor day attracted 60 investors from nine countries and provided more than 500 partnering...

Cell transdifferentiation specialist Mogrify Ltd raises US$16m
The company has developed a unique scalable technology for direct cellular transdifferentiation, based on the FANTOM5 dataset of human regulatory...

Magenta Therapeutics exercises ATAC licence option
Stem cell specialist Magenta Therapeutics (Cambridge, MA, USA) agreed to pay up to $85m in milestones for the rights to exclusively develop and...

Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...

CHMP selects drugs for EU market approval
The Committee supported the very first conditional marketing authorisation for Merck Sharp & Dohme B.V.’s Ervebo (Ebola Zaire Vaccine...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...

NSCLC: Bemcentinib + anti-PD1 triple PFS
Bergen Bio ASA announced the primary endpoint of 25% Overall Response Rate (ORR) has been met in predominantly PD-L1 negative/low NSCLC patients in a...